AmerisourceBergen Investor Presentation — November 2021

Document content

Cautionary note regarding forward -looking statements

Certain of the statements contained in this presentation are "forward -looking statements" within the meaning of Section 27A of t he Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 (the "Securities Exchange

Act"). Words such as "expect," "likely," "outlook," "forecast," "would," "could," "should," "can," "project," "intend," "plan ," "continue," "sustain," "synergy," "on track," "believe," "seek," "estimate," "anticipate," "may," "possible," "assume,"

variations of such words, and similar expressions are intended to identify such forward -looking statements. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances

and speak only as of the date hereof. These statements are not guarantees of future performance and are based on assumptions andestimates that could prove incorrect or could cause actual results to vary materially from those

indicated. Among the factors that could cause actual results to differ materially from those projected, anticipated, or impli ed are the following: unfavorable trends in brand and generic pharmaceutical pricing, including in rate or frequency of

price inflation or deflation; competition and industry consolidation of both customers and suppliers resulting in increasing pressure to reduce prices for our products and services; changes in the United States healthcare and regulatory

environment, including changes that could impact prescription drug reimbursement under Medicare and Medicaid; increasing gove rnmental regulations regarding the pharmaceutical supply channel; declining reimbursement rates for

pharmaceuticals; continued federal and state government enforcement initiatives to detect and prevent suspicious orders of co ntrolled substances and the diversion of controlled substances; continued prosecution or suit by federal, state